Net Investments: EUR6.9 billion, with 95% taxonomy aligned. Adjusted EBITDA: EUR4 billion, reaching over 75% of the lower end of full-year guidance. Adjusted Net Income: EUR1.6 billion, exceeding 85% ...

Adjusted EBITDA: EUR3.5 billion for the first nine months of 2025. Offshore Wind Adjusted EBITDA: EUR915 million, impacted by weak wind conditions and lower hedge prices. Onshore Wind and Solar EBITDA ...

RWE’s EPS beat expectations by a significant margin. Revenue missed forecasts, raising questions about sales growth. Stock price rose 5.51%, reflecting investor optimism. Strong performance in AI ...

Adjusted EBITDA: EUR1.3 billion for Q1 2025. Adjusted Net Income: EUR500 million for Q1 2025. Share Buyback Program: EUR1.5 billion, with the first EUR500 million tranche to be completed by the end of ...

DURHAM, N.C., Dec. 3, 2024 /PRNewswire/ -- Target RWE, a leader in real-world evidence solutions in liver disease, presented important research on the use of glucagon-like peptide-1 receptor agonists ...